These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4309848)

  • 1. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
    Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
    Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
    Miller FA; Sloan BJ; Silverman CA
    Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral activity of 9-beta-D-arabinofuranosyladenine. 3. Reduction in evidence of encephalitis in treated herpes Simplex-infected hamsters.
    Schardein JL; Sidwel RW
    Antimicrob Agents Chemother (Bethesda); 1968; 8():155-60. PubMed ID: 4309847
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
    Sidwell RW; Dixon GJ; Schabel FM; Kaump DH
    Antimicrob Agents Chemother (Bethesda); 1968; 8():148-54. PubMed ID: 5735359
    [No Abstract]   [Full Text] [Related]  

  • 5. The N6-(dimethylamino)methylene derivative of 9-beta-D-arabinofuranosyladenine as an antiviral agent.
    Hanessian S
    J Med Chem; 1973 Mar; 16(3):290-2. PubMed ID: 4354694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of desoxyribonuclease on herpes simplex virus].
    Kossak NI
    Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice.
    Dixon GJ; Sidwell RW; Miller FA; Sloan BJ
    Antimicrob Agents Chemother (Bethesda); 1968; 8():172-9. PubMed ID: 4309849
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal and neonatal herpes simplex virus infections.
    Keller DL
    N Engl J Med; 2009 Dec; 361(27):2678-9; author reply 2679. PubMed ID: 20050389
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
    Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
    Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpetic eye disease caused by herpes simplex virus].
    Ben-Simon G; Bareguet I
    Harefuah; 2001 Oct; 140(10):959-66. PubMed ID: 11681133
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on virus-inhibiting substances of bacterial origin. IV. Antiviral substances extractable from Streptococcus faecalis: its in vivo effect.
    Fujisaki M; Uchida S; Kojima M; Hotta S; Hamada C; Maeyama Y
    Kobe J Med Sci; 1978 Jun; 24(2):115-23. PubMed ID: 101714
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
    Sloan BJ; Miller FA; McLean IW
    Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of herpes simplex virus infections: a prospective view.
    Schwartz J; Elizan TS
    Mt Sinai J Med; 1973; 40(5):641-51. PubMed ID: 4125976
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antiviral activity and therapeutic efficacy of hydrophobized monoclonal antibodies against the herpes simplex virus].
    Kolomiets AG; Votiakov VI; Vladyko GV; Ovcharenko AV; Kabanov AV; Melik-Nubarov NS; Iaskovets NIu; Malakhova IV; Eremin VF; Moroz AG
    Dokl Akad Nauk SSSR; 1991; 317(6):1487-90. PubMed ID: 1654244
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections.
    Enright AM; Prober C
    Herpes; 2003 Aug; 10(2):32-7. PubMed ID: 14577952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
    Marks MI
    J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice.
    Hill JM; Wiggins CA; Kwon BS; Gentry GA; Gangarosa LP
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):17-20. PubMed ID: 6717166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiviral drugs that target herpesvirus helicase primase enzymes.
    Kleymann G
    Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.